资讯

Social media use is widespread and continues to grow. The most popular social media site, Facebook, is used by 68% of Americans and the average American spends over two hours a day on social media.
When something goes wrong with an AI assistant, our instinct is to ask it directly: "What happened?" or "Why did you do that?
Investors sold out of the biotech following a quarterly earnings release this morning. The company posted a deeper-than-expected net loss. 10 stocks we like better than Recursion Pharmaceuticals › ...
This was largely due to news from a rival clincal-stage biotech. Late on Friday, U.K.-based Biodexa announced it had launched a phase 3 clinical trial of its eRapa, an investigational drug that ...
REC-3565, a MALT1 inhibitor developed via AI, is now in Phase 1 for blood cancers. REC-617 showed encouraging signs in a patient with recurrent ovarian cancer. https ...
In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...
You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.
Running Python scripts is one of the most common tasks in automation. However, managing dependencies across different systems can be challenging. That’s where Docker comes in. Docker lets you package ...
When you install Python packages into a given instance of Python, the default behavior is for the package’s files to be copied into the target installation. But sometimes you don’t want to copy the ...
Have you ever found yourself wrestling with Excel formulas, wishing for a more powerful tool to handle your data? Or maybe you’ve heard the buzz about Python in Excel and wondered if it’s truly the ...
Former members tied to the Black Basta ransomware operation have been observed sticking to their tried-and-tested approach of email bombing and Microsoft Teams phishing to establish persistent access ...